首页> 外国专利> IDENTIFICATION, ISOLATION AND ELIMINATION OF CANCER STEM CELLS

IDENTIFICATION, ISOLATION AND ELIMINATION OF CANCER STEM CELLS

机译:肿瘤干细胞的鉴定,分离和消除

摘要

Isolated populations of leukemic stem cells are provided. The cells are useful for experimental evaluation, and as a source of lineage and cell specific products, and as targets for the discovery of factors or molecules that can affect them. Detection of leukemic stem cells is useful in predicting disease progression, relapse, and development of drug resistance. Proliferation of LSC may be inhibited through interfering with activation of the b­catenin pathway. Methods are provided for the clinical staging of pre-leukemia and leukemias by differential analysis of hematologic samples for the distribution of one or more hematopoietic stem or progenitor cell subsets.
机译:提供了白血病干细胞的分离群体。这些细胞可用于实验评估,可作为谱系和细胞特异性产物的来源,也可作为发现可能影响它们的因子或分子的靶标。白血病干细胞的检测可用于预测疾病的进展,复发和耐药性的发展。 LSC的增殖可通过干扰bcatenin途径的激活来抑制。通过对血液样本进行差异分析以提供一种或多种造血干细胞或祖细胞亚群的分布,为白血病前期和白血病的临床分期提供了方法。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号